Ryo Morisue
Kashiwa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Mutant p53 exploits enhancers to elevate immunosuppressive chemokine expression and impair immune checkpoint inhibitors in pancreatic cancer.
Journal: Immunity
Published: September 27, 2024
Mutant p53 Exploits Enhancers to Elevate Immunosuppressive Chemokine Expression and Impair Immune Checkpoint Inhibitors in Pancreatic Cancer.
Journal: bioRxiv : the preprint server for biology
Published: September 11, 2024
PI3 expression predicts recurrence after chemotherapy with DNA-damaging drugs in gastric cancer.
Journal: The Journal of pathology
Published: September 03, 2024
Common clinicopathological and immunological features of sarcomatoid carcinoma across organs: A histomorphology-based cross-organ study.
Journal: International journal of cancer
Published: January 17, 2023
Cancer-associated fibroblast-dependent and -independent invasion of gastric cancer cells.
Journal: Journal of cancer research and clinical oncology
Published: October 10, 2022
Dirty necrosis in renal cell carcinoma is associated with NETosis and systemic inflammation.
Journal: Cancer medicine
Published: March 05, 2022
Evaluation of the morphological features and unfavorable prognostic impact of dirty necrosis in renal cell carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: October 14, 2020
Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses.
Journal: International journal of cancer
Published: October 08, 2020
Tumor-Infiltrating T Cells Concurrently Overexpress CD200R with Immune Checkpoints PD-1, CTLA-4, and TIM-3 in Non-Small-Cell Lung Cancer.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: August 19, 2020
Last Updated: 09/26/2026